Author: Customer Service

TORONTO, Dec. 20, 2024 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased to announce its financial and operational results for the year ended August 31, 2024, the highlights of which are included in this news release. All figures are reported in Canadian dollars. The Company’s full set of consolidated audited financial statements for the years ended August 31, 2024 and 2023 and accompanying management’s discussion and analysis can be accessed by visiting the Company’s website at www.PharmAla.ca and its profile page on SEDAR+ at www.sedarplus.ca. “While the previous year saw significant setbacks for some companies,...

Transaction Unifies Two Leaders in Decentralization, Rumble CEO Retains Controlling Stake Strategic Investment Results in Mission-Aligned Investor and Supporter Rumble Will Use $250 Million of Proceeds to Further Solidify Balance Sheet and Accelerate Growth Initiatives Remaining Proceeds Will Be Used to Fund Self Tender Offer for up to 70 Million of Rumble’s Class A Common Stock to Provide Liquidity to Stockholders at Same Price as Tether Investment LONGBOAT KEY, Fla., Dec. 20, 2024 (GLOBE NEWSWIRE) — Rumble (NASDAQ:RUM) (“Rumble” or the “Company”), the video-sharing platform and cloud services provider, announced today that it has entered into a definitive agreement for a strategic investment of $775 million from Tether ($USDT) (“Tether”), the largest company in the digital assets industry and the most widely used dollar stablecoin...

MIAMI and BARRANQUILLA, Colombia, Dec. 20, 2024 (GLOBE NEWSWIRE) — Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced significant outcomes from its recent Shareholders Meeting and subsequent Board of Directors meeting. These include changes to the Board composition, restructuring of Board committees, and updates to its executive leadership team. The Shareholders Meeting marked an important milestone with the election of new members to the Board of Directors. The newly elected members bring a diverse range of expertise and strategic insight to guide Procaps’ future growth. Newly appointed Board members include:Mr. Alejandro Weinstein, Executive Chairman of the board Mr. Nicolas Weinstein Mr. Ernesto Carrizosa Mr. Jose FrugoneThe...

Roseland, NJ, Dec. 20, 2024 (GLOBE NEWSWIRE) — Gaxos.ai Inc. (Nasdaq: GXAI), (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various sectors, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of an aggregate of 1,449,277 shares of its common stock at a purchase price of $3.45 per share. In addition, in a concurrent private placement, the Company issued unregistered warrants to purchase up to 1,449,277 shares of common stock. The warrants have an exercise price of $3.32 per share, are exercisable upon issuance and expire three years following the date of issuance.  H.C. Wainwright & Co. acted as the exclusive placement agent for the offering. The aggregate gross proceeds to the Company...

STAMFORD, Conn., Dec. 20, 2024 (GLOBE NEWSWIRE) — The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”), the home furnishing brand best known for its Sactionals, The World’s Most Adaptable Couch, has released its ESG & Impact Report for the 2024 fiscal year ended February 4, 2024. This report highlights the company’s continued commitment to environmental sustainability, social responsibility, and governance (“ESG”). Shawn Nelson, Chief Executive Officer, stated, “Lovesac’s commitment to sustainability and responsible business practices is at the heart of our operations. We are dedicated to creating products that are Designed for Life, reducing our environmental impact, and fostering a culture of integrity and responsibility. Our ESG pillars of Earth, Love, and Purpose guide us in making decisions that...

EL SEGUNDO, Calif., Dec. 20, 2024 (GLOBE NEWSWIRE) —   With a mission to positively impact human health, climate change, constraints on natural resources and animal welfare, Beyond Meat, Inc. (NASDAQ: BYND), a leader in plant-based meat, today released its 2023 ESG Report and announced its Beyond Steak life cycle assessment (LCA) study. Beyond Meat’s 2023 ESG Report covers topics such as health and nutrition, human capital, governance and climate management. The company has expanded its disclosures on climate and its approach to ESG, including a corporate-level GHG inventory across the company’s direct and indirect emissions (Scope 1, 2 and 3), an assessment of climate-related financial risk and opportunity, and an updated ESG materiality analysis. The 2023 ESG Report also includes the results of Beyond Meat’s recently completed...

TEL AVIV, Israel, Dec. 20, 2024 (GLOBE NEWSWIRE) —  Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its fourth quarter and full year 2024 financial results, as well as on its financial guidance for 2025, on Wednesday, January 29, 2025, at 7:00 a.m. ET. Following the release, Teva will conduct a conference call and live webcast on the same day, at 8:00 a.m. ET. In order to participate, please register in advance here to obtain a local or toll-free phone number and your personal pin. A live webcast of the call will be available on Teva’s website at: https://ir.tevapharm.com/Events-and-Presentations. Following the conclusion of the call, a replay of the webcast will be available within 24 hours on Teva’s website. About Teva Teva Pharmaceutical Industries Ltd....

Net loss of $9.2 million for the quarter inclusive of a $6.3 million non-cash charge for contingent obligation, compared with a net loss of $5.1 million for the prior year quarter. Net loss on a non-GAAP basis was $1.3 million for the quarter, representing a 56% improvement from the third quarter of 2023, and $3.4 million for the nine months ended September 30, 2024, representing a 60% improvement from the prior year comparable period. Adjusted EBITDA for the quarter was negative $1.0 million, compared with Adjusted EBITDA of negative $1.4 million for the prior year quarter. Direct Operating Costs and Expenses of $2.8 million for the quarter, a 50% improvement from the prior year quarter.NEW YORK, Dec. 20, 2024 (GLOBE NEWSWIRE) — Xcel Brands, Inc. (NASDAQ: XELB) (“Xcel” or the “Company”), a media and consumer products company...